内镜下套扎术治疗内痔54例前瞻性研究

Endoscopic ligation for hemorrhoidal disease: prospective results in 54 patients

摘要:

摘要：目的??研究微创治疗内痔新方法内镜下套扎术治疗内痔的疗效及安全性。方法 收集2017年2月－2018年2月于该院行内镜下套扎术治疗的54例Ⅱ至Ⅲ期内痔患者，随访1、6和12个月，观察患者症状改善情况、并发症发生及复发情况，应用疼痛评分、出血评分、生活质量评分和脱出程度评分来评估内镜下套扎术的疗效及安全性。结果 术后随访12个月，47例治疗有效，治疗有效率87.0%，均未出现严重并发症，进行疼痛视觉模拟评分（VAS）、出血评分、生活质量及脱出程度评分，对比治疗前后，各个指标均有明显下降，VAS评分由（3.9±2.1）分降至（1.9±1.1）分（P?=?0.012），出血评分由（5.5±2.4）分降至（2.3±1.5）分（P?=?0.000），生活质量评分由（2.6±0.7）分降至（1.2±0.6）分（P?=?0.039），脱出程度评分由（2.4±0.5）分降至（1.6±0.6）分（P?=?0.002），2例（3.7%）患者出现复发，分别发生于10和11个月。结论 内镜下套扎术治疗内痔临床疗效确切，是一种安全有效的治疗方法。

Abstract:

Abstract: Objective?To evaluate the efficacy and safety of endoscopic ligation for hemorrhoidal disease as a first-line invasive treatment.?Methods?This prospective study was conducted from Feburary 2017 to Feburary 2018 on 54 consecutive patients with grade II-III hemorrhoids. Endoscopic ligation was performed. Over the following 1 month, 6 months, 12 months, the improvement of symptoms, occurrence of complications and recurrence were observed. Clinical outcomes were evaluated using the visual analog scale (VAS) score for pain, French bleeding score, quality-of-life score and prolapse score.?Results?At 12 months after ligation, clinical success was obtained in 47 patients (87.0%), no patients experienced any serious complications.all indexes evaluated were decline significantly. VAS score decreased from (3.9?±?2.1) to (1.9?±?1.1) (P?=?0.012), and bleeding score decreased from (5.5?±?2.4) to (2.3?±?1.5) (P?=?0.000). Quality-of-life score decreased from (2.6?±?0.7) to (1.2?±?0.6) (P?=?0.039) and prolapse scores decreased from (2.4?±?0.5) to (1.6?±?0.6) (P?=?0.002), and recurrence were observed in 2 patients (3.7%), occurred after 10 and 11 month.?Conclusions?Endoscopic ligation was found to be a safe and effective treatment for hemorrhoids.